WEST PHARMACEUTICAL SERVICES, INC. Funds and ETFs West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 368.5 USD | +1.38% |
|
+0.08% | +4.64% |
| 26/04 | Declaration of Voting Results of the West Pharmaceutical Services Inc | CI |
| 26/04 | Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc | CI |
ETFs positioned on West Pharmaceutical Services, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.04% | 5 M€ | -1.80% | - | |
| 1.44% | 16 M€ | -4.51% | ||
| 1.02% | 18 M€ | +3.01% | - | |
| 0.95% | 2 M€ | +6.77% | ||
| 0.81% | 1 M€ | +2.21% | - | |
| 0.80% | 267 M€ | +6.08% | ||
| 0.59% | 4,592 M€ | +11.18% | ||
| 0.30% | 2 M€ | +20.44% | - | |
| 0.27% | 469 M€ | -2.05% | - | |
| 0.27% | 3,859 M€ | +18.82% | - | |
| 0.27% | 9 M€ | -.--% | - | |
| 0.19% | 40 M€ | -.--% | ||
| 0.17% | 5 M€ | -72.95% | - | |
| 0.16% | 219 M€ | +17.17% | - | |
| 0.16% | 1,448 M€ | -.--% | - | |
| 0.15% | 2,510 M€ | +10.19% | ||
| 0.15% | 330 M€ | -.--% | - | |
| 0.15% | 52 M€ | +5.64% | ||
| 0.15% | 2 M€ | +14.69% | - | |
| 0.13% | 10 M€ | +5.46% | ||
| 0.11% | 29 M€ | -.--% | - | |
| 0.11% | 322 M€ | +13.88% | - | |
| 0.11% | 1,006 M€ | -.--% | - | |
| 0.11% | 414 M€ | +8.57% | - | |
| 0.10% | 277 M€ | -.--% | - | |
| 0.10% | 194 M€ | +6.53% | - | |
| 0.10% | 441 M€ | +9.04% | ||
| 0.10% | 36 M€ | -.--% | ||
| 0.10% | 9 M€ | +2.08% | - | |
| 0.10% | 736 M€ | +6.44% |
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows:
- own manufactured products (81.8%);
- products manufactured under contract (18.2%).
Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Calendar
25/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
368.5
USD
Average target price
397.1
USD
Spread / Average Target
+7.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.64% | 26.84B | |
| -3.77% | 184B | |
| -1.77% | 107B | |
| -1.43% | 69.44B | |
| +2.06% | 50.37B | |
| +9.43% | 44.82B | |
| +3.40% | 41.53B | |
| +3.04% | 26.73B | |
| +15.23% | 25.71B | |
| -2.66% | 24.34B |
- Stock Market
- Equities
- WST Stock
- Funds and ETFs West Pharmaceutical Services, Inc.
